source
- Indivior ends Addex PAM collaboration as it prepares for Supernus mergerIndivior Pharmaceuticals has terminated its long‑standing partnership with Addex Therapeutics that focused on developing positive allosteric modulators (PAMs) for addiction treatment. The collabor…
- Jury awards Nektar $90 million in damages after lawsuit over broken rezpeg partnership with Eli LillyA jury in a US court has ordered Eli Lilly to pay Nektar Therapeutics $90 million after finding the pharma giant breached their collaboration on the experimental autoimmune drug rezpeg. Nektar and…